Tag: FDA guidance
Bioequivalence of Combination Products: Special Testing Challenges
Bioequivalence testing for combination products like FDCs, inhalers, and topical creams is far more complex than for single-drug generics. Regulatory, technical, and financial hurdles delay affordable access to life-saving medications.
read morerecent posts
Explore how FDA REMS programs manage high-risk medications through ETASU and registries to ensure patient safety while balancing drug accessibility.
Published ON: 21 AprExplore why generic drug availability and pricing vary so wildly across the globe, from the US and UK to India and Switzerland.
Published ON: 10 AprLearn about ptosis and entropion, how they affect your vision, and the surgical options available to correct eyelid malposition and protect your sight.
Published ON: 9 AprLearn how to save money on generic Ciprofloxacin in 2026. Compare online pharmacy prices, understand prescription requirements, and find the safest cheap options.
Published ON: 16 AprLearn how to interpret the FDA's Pregnancy and Lactation Labeling Rule (PLLR), moving from old A-X categories to detailed narrative safety summaries.
Published ON: 7 Apr